馬匹醫療保健市場規模、佔有率和成長分析（按產品類型、疾病類型、分銷管道、最終用戶和地區）- 產業預測 2025-2032

馬匹醫療保健市場規模預計到 2023 年將達到 37.9 億美元，並從 2024 年的 40.6 億美元成長到 2032 年的 69.7 億美元，預測期內（2025-2032 年）的複合年成長率為 7.0%。

由於研發舉措加大、馬匹健康併發症增加以及馬匹治療方法的接受度不斷提高，馬匹醫療保健市場正在經歷強勁成長。人工智慧（AI）的引入對該領域產生了重大影響，激發了致力於將該技術融入馬科動物實踐的獸醫研究人員的創新。主要企業正在積極支持這些進步，以應對持續存在的挑戰，並透過及時的健康評估加強醫療管理。這項技術的進步正在提高馬匹的早期疾病診斷和個人化治療。馬匹健康照護包括預防性照護、疾病管理、跛足治療、生殖照護和解決行為問題，最終改善馬匹的整體健康狀況、早期發現疾病並延長馬匹的壽命。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 案例研究
• 監管格局
• 專利分析

馬匹醫療保健市場規模（按產品類型和複合年成長率） (2025-2032)

• 市場概況
• 藥物
• 疫苗
• 藥物飼料添加劑

馬匹醫療保健市場規模（按疾病類型和複合年成長率） (2025-2032)

• 市場概況
• 馬流感
• 馬皰疹病毒
• 馬腦脊髓炎
• 馬西尼羅河病毒
• 其他

馬匹醫療保健市場規模（按分銷管道和複合年成長率） (2025-2032)

• 市場概況
• 獸醫診所
• 獸醫診所
• 零售藥局
• 網路藥局

馬匹醫療保健市場規模（按最終用戶和複合年成長率） (2025-2032)

• 市場概況
• 獸醫診所
• 獸醫診所
• 其他

馬匹醫療保健市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司詳細資訊
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Zoetis Inc.（USA）
• Merck Animal Health（USA）
• Boehringer Ingelheim International GmbH（Germany）
• Elanco Animal Health（USA）
• Bayer AG（Germany）
• Ceva Sante Animale（France）
• Virbac（France）
• Dechra Pharmaceuticals PLC（UK）
• IDEXX Laboratories, Inc.（USA）
• Vetoquinol SA（France）
• Norbrook Laboratories Limited（UK）
• EQUINE PRODUCTS UK LTD（UK）
• KRKA（Slovenia）
• HIPRA（Spain）
• Luitpold Pharmaceuticals, Inc.（USA）
• Affymetrix Inc.（USA）
• Sanofi（France）
• Novartis Animal Health（Switzerland）
• Signostics（Australia）
• Merial（USA）

結論和建議

Equine Healthcare Market size was valued at USD 3.79 billion in 2023 and is poised to grow from USD 4.06 billion in 2024 to USD 6.97 billion by 2032, growing at a CAGR of 7.0% during the forecast period (2025-2032).

The equine healthcare market is experiencing robust growth, driven by a surge in research and development initiatives, a rise in equine health complications, and the increasing acceptance of equine-based therapies. The introduction of artificial intelligence (AI) is significantly impacting the sector, fostering innovation among veterinary researchers focused on integrating this technology into equine practices. Leading companies are actively supporting these advancements to tackle persistent challenges and enhance healthcare management through timely health assessments. This technological evolution is enhancing early disease diagnosis and personalized treatments for horses. Equine healthcare encompasses preventive care, illness management, lameness treatment, reproductive care, and addressing behavioral issues, ultimately promoting better overall health, early disease detection, and longevity for equine companions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Equine Healthcare market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Equine Healthcare Market Segments Analysis

Global Equine Healthcare Market is segmented by Product Type, Disease Type, Distribution Channel, End User and region. Based on Product Type, the market is segmented into Drugs, Vaccines and Medical Feed Additives. Based on Disease Type, the market is segmented into Equine Influenza, Equine Herpesvirus, Equine Encephalomyelitis, Equine West Nile Virus and Others. Based on Distribution Channel, the market is segmented into Veterinary Hospitals, Veterinary Clinics, Retail Pharmacies and Online Pharmacies. Based on End User, the market is segmented into Veterinary Hospitals, Veterinary Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Equine Healthcare Market

The Equine Healthcare market is experiencing robust growth, fueled by the surging popularity of equine sports and recreational activities. Events such as horse racing, show jumping, and dressage necessitate the maintenance of healthy and well-cared-for horses, thereby driving demand for healthcare products and services. This heightened enthusiasm for equine activities has led to increased investments in vaccinations, nutritional supplements, and grooming essentials, all aimed at promoting the overall well-being of horses. As more individuals engage in these activities, the need for comprehensive equine healthcare solutions expands, highlighting the market's potential for continued development and innovation.

Restraints in the Equine Healthcare Market

The Equine Healthcare market is significantly hindered by the high costs associated with equine medical products and services. Veterinary care for horses, including surgeries, specialized therapies, and routine check-ups, can be prohibitively expensive for small facilities. Although advanced diagnostic tools and treatments may offer effective solutions, their financial implications can pose serious challenges. This financial burden is particularly pronounced in emerging economies where disposable incomes are limited, further restricting the market's growth potential. As a result, the steep costs of necessary equine healthcare services deter investment and accessibility, ultimately impacting the overall development of the industry.

Market Trends of the Equine Healthcare Market

The incorporation of telemedicine in equine healthcare is emerging as a significant market trend, revolutionizing how veterinary services are delivered to horse owners. As digital platforms gain traction, veterinarians can now conduct consultations, monitor recovery, and provide expert guidance remotely, enhancing accessibility for horse owners, especially in rural or remote areas where advanced care may be scarce. This shift not only improves the convenience and efficiency of veterinary services but also reduces the costs associated with transporting horses for routine check-ups and minor treatments. As a result, telemedicine is expected to play a pivotal role in shaping the future of equine healthcare.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Patent Analysis

Global Equine Healthcare Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Drugs
• Vaccines
• Medical Feed Additives

Global Equine Healthcare Market Size by Disease Type & CAGR (2025-2032)

• Market Overview
• Equine Influenza
• Equine Herpesvirus
• Equine Encephalomyelitis
• Equine West Nile Virus
• Others

Global Equine Healthcare Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Veterinary Hospitals
• Veterinary Clinics
• Retail Pharmacies
• Online Pharmacies

Global Equine Healthcare Market Size by End User & CAGR (2025-2032)

• Market Overview
• Veterinary Hospitals
• Veterinary Clinics
• Others

Global Equine Healthcare Market Size & CAGR (2025-2032)

• North America (Product Type, Disease Type, Distribution Channel, End User)
  • US
  • Canada
• Europe (Product Type, Disease Type, Distribution Channel, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Disease Type, Distribution Channel, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Disease Type, Distribution Channel, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Disease Type, Distribution Channel, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Zoetis Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Animal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim International GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elanco Animal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ceva Sante Animale (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dechra Pharmaceuticals PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IDEXX Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vetoquinol S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Norbrook Laboratories Limited (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EQUINE PRODUCTS UK LTD (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• KRKA (Slovenia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HIPRA (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Luitpold Pharmaceuticals, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Affymetrix Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis Animal Health (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Signostics (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merial (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations